Oxbow Advisors LLC Makes New Investment in HealthEquity, Inc. $HQY

Oxbow Advisors LLC bought a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) during the first quarter, Holdings Channel reports. The fund bought 37,653 shares of the company’s stock, valued at approximately $3,147,000.

Other large investors have also modified their holdings of the company. HB Wealth Management LLC purchased a new stake in shares of HealthEquity in the 1st quarter worth approximately $229,000. New York State Teachers Retirement System boosted its stake in shares of HealthEquity by 6.5% during the first quarter. New York State Teachers Retirement System now owns 83,898 shares of the company’s stock valued at $7,011,000 after purchasing an additional 5,095 shares in the last quarter. Leonteq Securities AG increased its holdings in HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after buying an additional 235 shares during the period. Elevation Point Wealth Partners LLC bought a new position in HealthEquity in the first quarter worth approximately $488,000. Finally, Fulton Bank N.A. raised its stake in HealthEquity by 27.0% in the first quarter. Fulton Bank N.A. now owns 6,526 shares of the company’s stock worth $545,000 after buying an additional 1,389 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

NASDAQ HQY opened at $95.31 on Friday. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The firm has a market cap of $7.97 billion, a PE ratio of 35.70, a price-to-earnings-growth ratio of 1.60 and a beta of 0.21. The company has a 50 day moving average price of $86.04 and a 200 day moving average price of $84.67. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $105.96.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The business’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, sell-side analysts forecast that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on HQY shares. Royal Bank Of Canada upped their target price on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a report on Wednesday, June 3rd. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday. Deutsche Bank Aktiengesellschaft boosted their price target on HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research report on Thursday, March 19th. Wells Fargo & Company set a $111.00 price objective on HealthEquity in a research note on Monday, June 1st. Finally, JPMorgan Chase & Co. dropped their price objective on HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 18th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $110.57.

Insider Transactions at HealthEquity

In related news, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the transaction, the executive vice president directly owned 59,113 shares in the company, valued at $5,615,735. The trade was a 5.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director owned 19,733 shares in the company, valued at approximately $1,775,970. This trade represents a 11.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 13,081 shares of company stock valued at $1,193,000. Corporate insiders own 1.60% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.